{"title":"Preface of the European Ombudsman: Transparency and Participation in the Face of Scientific Uncertainty","authors":"Emily O’Reilly","doi":"10.1017/err.2023.35","DOIUrl":null,"url":null,"abstract":"The article provides information on the importance of transparency in decision-making processes, particularly in relation to scientific advice and the COVID-19 pandemic. It highlights the need for clear communication and proactive publication of information, as well as the disclosure of changes in advice based on new scientific evidence, in order to maintain public trust and counter disinformation.","PeriodicalId":46207,"journal":{"name":"European Journal of Risk Regulation","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Risk Regulation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/err.2023.35","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"LAW","Score":null,"Total":0}
引用次数: 0
Abstract
The article provides information on the importance of transparency in decision-making processes, particularly in relation to scientific advice and the COVID-19 pandemic. It highlights the need for clear communication and proactive publication of information, as well as the disclosure of changes in advice based on new scientific evidence, in order to maintain public trust and counter disinformation.
期刊介绍:
European Journal of Risk Regulation is an interdisciplinary forum bringing together legal practitioners, academics, risk analysts and policymakers in a dialogue on how risks to individuals’ health, safety and the environment are regulated across policy domains globally. The journal’s wide scope encourages exploration of public health, safety and environmental aspects of pharmaceuticals, food and other consumer products alongside a wider interpretation of risk, which includes financial regulation, technology-related risks, natural disasters and terrorism.